A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 21
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : ENRD
Long Form : endoscopy negative reflux disease
No. Year Title Co-occurring Abbreviation
2019 Convenient Method of Measuring Baseline Impedance for Distinguishing Patients with Functional Heartburn from those with Proton Pump Inhibitor-Resistant Endoscopic Negative Reflux Disease. BI, FH, MBI, MNBI, NERD, PPI
2018 Impaired motility in Barrett's esophagus: A study using high-resolution manometry with physiologic challenge. BE, FHC, HRM, RDC
2017 Gastroesophageal Reflux Disease and its Association with Body Mass Index: Clinical and Endoscopic Study. BMI, GERD, GI
2015 Pathophysiology of functional heartburn based on Rome III criteria in Japanese patients. CMI, FH, GSRS, HE, pH-POS, PPI, QUEST
2013 Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease. CI, GORD, H2RA, PPI, RR
2011 Failure to respond to physiologic challenge characterizes esophageal motility in erosive gastro-esophageal reflux disease. ERD, GERD, MWS
2010 Efficacy of three different dosages of esomeprazole in the long-term management of reflux disease: a prospective, randomized study, using the wireless Bravo pH system. GERD, PPIs
2010 Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease. CI, GORD, H2RA, PPI, RR
2006 Prospective, randomized, and active controlled study of the efficacy of alginic acid and antacid in the treatment of patients with endoscopy-negative reflux disease. VAS
10  2006 Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease. CI, GORD, H2RA, PPI, RR
11  2005 [Prevalence of different groups that comprise endoscopy-negative reflux disease]. NERD
12  2004 Review article: approaches to endoscopic-negative reflux disease: part of the GERD spectrum or a unique acid-related disorder? GERD
13  2004 Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease. CI, GORD, H2RA, PPI, RR
14  2003 Medical management of nocturnal symptoms of gastro-oesophageal reflux disease in the elderly. GORD
15  2003 Short-term treatment of gastroesophageal reflux disease. GERD, H2RAs, PPIs, SRR
16  2002 Pathological issues of gastric and lower esophageal cancer: helicobacter pylori infection and its eradication. GERD, HP
17  2001 Endoscopy-negative reflux disease. PPI
18  2001 Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease. GORD, H2RA, PPI, RR
19  2001 Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease. GERD
20  2000 Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease. GORD, H2RA, PPI, RR
21  1999 Endoscopic evaluation of gastro-esophageal reflux disease. GERD